X0508 4 2024-07-02 true 0001850266 Akili, Inc. AKLI 0001928033 Gazzaley Adam C/O AKILI, INC. 71 COMMERCIAL ST, MAILBOX 312 BOSTON MA 02109 true false false false false Common Stock, par value $0.0001 2024-07-02 4 U false 1089314.00 D 0.00 D Reflects disposition of shares of common stock (each, a "Share") of the Issuer at a price per Share of $0.4340 (the "Offer Price") pursuant to the terms of that certain Agreement and Plan of Merger (the "Merger Agreement"), dated as of May 29, 2024, by and among the Issuer, Virtual Therapeutics Corporation, a Delaware corporation ("Parent") and Alpha Merger Sub, Inc., a Delaware corporation and a wholly-owned subsidiary of Parent ("Purchaser"), Purchaser completed a tender offer for shares of common stock of the Issuer and thereafter merged with and into the Issuer, effective as of July 2, 2024 (the "Effective Time") with the Issuer surviving the merger. As of the Effective Time, each Share held by the Reporting Person or his affiliates was converted into the Offer Price. /s/ Jacqueline Studer, attorney-in-fact 2024-07-02